Dr. Lakshmikuttyamma Ashakumary Lakshmikuttyamma, PhD, MSc

Contact Dr. Lakshmikuttyamma

130 South 9th Street
Suite 1510
Philadelphia, PA 19107

(215) 503-6862
(215) 503-9052 fax

Education
PhD, Biochemistry, University of Kerala, India

MSc, Biochemistry, University of Kerala, India

Postdoctoral Fellowships
National Food Research Institute, Tsukuba, Japan

University of Saskatchewan, Saskatoon, Canada

University Appointment
Research Instructor

Professional Organizations
ASPET
Society for Neuroscience

Research/Clinical Interests
My primary research interest is on the epigenetic basis of cancer, I am also interested in examining the epigenetic bases of disorders such as depression and drug addiction. Epigenetic changes involve alterations in chromatin structure and DNA methylation. The molecular mechanisms underlying the epigenetic regulation in cancer and various psychiatric disorders have not been fully understood. Many tumor suppressor genes are silenced through aberrant DNA methylation and alteration in chromatin modification during the disease progression. My research is focused on polycomb complex and its influence on epigenetic regulation of tumor suppressor genes in leukemia, this leads to the identification of novel epigenetic target in leukemia for unique therapeutic interventions and to understand the complex mechanism of this disease.

Epigenetic risk factors for psychiatric disorders are based on the concept that epigenetic events modify the activation or inactivation of several genes involved in the normal function of brain. My research involves the epigenetic genome wide sequencing of specific brain sections to identify the epigenetic markers in depression and addiction.

Publications

Most recent Peer-reviewed Publications

  1. Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition
  2. Biochemical characterization of bovine brain myristoyl-CoA:Protein N-myristoyltransferase type 2
  3. NC2213: A novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells
  4. RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression
  5. Cardiac high molecular weight calmodulin-binding protein is homologous to calpastatin I and calpastatin II
  6. Cardiac high molecular weight calmodulin-binding protein is homologous to calpastatin I and calpastatin II
  7. Bcr-Abl induces autocrine IGF-1 signaling
  8. Myristoyltransferase and calcineurin: Novel molecular therapeutic target for epilepsy
  9. Interaction of heat shock protein 70 with calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE 1B1)
  10. Potential role of N-myristoyltransferase in cancer
  11. Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): Review
  12. Methionine aminopeptidase 2 and cancer
  13. Interaction between heat shock protein 70 kDa and calcineurin in cardiovascular systems (review)
  14. Expression of calcineurin and its interacting proteins in epileptic fowl
  15. Molecular cloning, expression, purification and characterization of calcineurin from bovine cardiac muscle
  16. Expression of myristoyltransferase and its interacting proteins in epilepsy
  17. Increased expression of calcineurin in human colorectal adenocarcinomas
  18. Involvement of calcineurin in ischemic myocardial damage
  19. N-myristoyltransferase inhibitor protein is homologous to heat shock cognate protein 70
  20. Molecular cloning of bovine cardiac muscle heat-shock protein 70 kDa and its phosphorylation by cAMP-dependent protein kinase in vitro

View All Publications